All the Active Ingredient Drugs
Haemophilus Influenzae type b 10 mcg / 0.5 ml. VIALS: (pwdr.) 1 + syringe: 0.5 ml. I.M or
S.C. route. See lit.
Prevent. in inf. against invas. dis.
caused by H. influenza type B such as
meningit., septicem., cellulit., arthrit.,
epiglotit.
C/I: Hypersens., espec. tetanus protein.
Bacterial and Viral Vaccines. Diphtheria Toxoid NLT 30 IU/dose, Filamentous Haemagglutinin 25 mcg/dose, Haemophilus Influenzae type b 10 mcg/dose, Hepatitis B Vaccine 10 mcg/dose, Pertactin 8 mcg/dose, Pertussis Toxoid 25 mcg/dose, Inactivated Poliovirus type 1 40 DU/dose, Inactivated Poliovirus type 2 8 DU/dose, Inactivated Poliovirus type 3 32 DU/dose, Tetanus Toxoid NLT 40 IU/dose. RECONSTITUTED VACCINE: 1. 3 doses in
first 6 mths of life start. at 2 mths.
Booster dose: 2nd year of life. by deep
I.M. inject. at alt. sites for ea. inject. See
lit.
Active immunizant. from 2 mths. - 7 yrs.
against diphth., tetanus, pertussis (DTP)
and Hib.
C/I: Febrile illness, hypersens. to vaccine,
acute infect, past neurolog. complicats.
See lit.
Bacterial and Viral Vaccines. Diphtheria Toxoid NLT 30 IU / 0.5 ml, Filamentous Haemagglutinin 25 mcg / 0.5 ml, Haemophilus Influenzae type b 10 mcg / 0.5 ml, Inactivated Poliovirus type 1 40 DU / 0.5 ml, Inactivated Poliovirus type 2 8 DU / 0.5 ml, Inactivated Poliovirus type 3 32 DU / 0.5 ml, Pertactin 8 mcg / 0.5 ml, Pertussis Toxoid 25 mcg / 0.5 ml, Tetanus Toxoid NLT 40 IU / 0.5 ml. PREFILLED SYRINGE/MONOVIAL: 0.5 ml.
Prim. vac: 3 doses, in 1st 6 mths. of life
starting from 2 mths. Interval of at
least 1 mth betw. subsequent doses. A
booster dose in 2nd yr. life. All by I.M.
inject. in anterolateral aspect of thigh.
Active immunizat. infants from 2 yrs-5
yrs against diphth., tet. pertussis, polio.,
and hemophilus influ. type b. Booster
dose for child. prev. immuniz. with DTD,
polio and Hib antigen.
C/I: Febrile illness, hypersens. to vaccine,
acute infect, past neurolog. complicats.